Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
785.51
+18.88 (+2.46%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
671,659
Open
769.63
Bid (Size)
781.37 (40)
Ask (Size)
787.00 (480)
Prev. Close
766.63
Today's Range
764.78 - 786.99
52wk Range
476.49 - 821.11
Shares Outstanding
91,779,465
Dividend Yield
0.45%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Great Reversal: Tariffs Ignite Goods Inflation as Services Cool in Latest PCE Data
February 06, 2026
The latest Personal Consumption Expenditures (PCE) price index data has revealed a significant shift in the U.S. inflationary landscape, presenting a complex puzzle for the Federal Reserve. As of early...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Regeneron (REGN) Q1 2025 Earnings Call Transcript
↗
February 05, 2026
Regeneron (REGN) Q1 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Supply Chain
Performance
YTD
+1.2%
+1.2%
1 Month
-3.3%
-3.3%
3 Month
+19.5%
+19.5%
6 Month
+39.5%
+39.5%
1 Year
+8.8%
+8.8%
More News
Read More
Regeneron (REGN) Q2 2025 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Regeneron Stock Slips Premarket Even After Wall Street Lifts Targets On Strong Q4 — What’s Weighing On The Stock?
↗
February 02, 2026
Via
Stocktwits
Regeneron Pharmaceuticals (NASDAQ:REGN) Reports Q4 2025 Earnings Beat Amid Product Transition
↗
January 30, 2026
Via
Chartmill
Topics
Earnings
Regeneron (REGN) Q4 2024 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Regeneron (REGN) Q3 2024 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
February 02, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
This $24 Million Buy Amid a 45% Stock Drop Signals Conviction in a High-Margin Data Business
↗
January 30, 2026
Via
The Motley Fool
Regeneron (REGN) Q4 2025 Earnings Call Transcript
↗
January 30, 2026
Via
The Motley Fool
Topics
Earnings
These S&P500 stocks that are showing activity before the opening bell on Friday.
↗
January 30, 2026
Via
Chartmill
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock
↗
January 30, 2026
Via
Stocktwits
Regeneron (NASDAQ:REGN) Posts Better-Than-Expected Sales In Q4 CY2025
January 30, 2026
Via
StockStory
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
January 30, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow
January 28, 2026
Via
StockStory
Topics
Artificial Intelligence
2 Healthcare Stocks Poised for a Comeback in 2026
↗
January 22, 2026
Via
The Motley Fool
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
Via
MarketMinute
Topics
Intellectual Property
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
↗
January 19, 2026
Via
MarketBeat
Topics
ETFs
3 Profitable Stocks We Think Twice About
January 18, 2026
Via
StockStory
1 Mooning Stock with Exciting Potential and 2 Facing Headwinds
January 12, 2026
Via
StockStory
Topics
Economy
Energy
Regeneron Just Moved From Underperform To Buy - Here's Why
↗
January 07, 2026
Via
Benzinga
These S&P500 stocks are moving in today's session
↗
January 07, 2026
Via
Chartmill
Why Regeneron (REGN) Stock Is Trading Up Today
January 07, 2026
Via
StockStory
Topics
Artificial Intelligence
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
January 02, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 785.51
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 02/06/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 72.09B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 72B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.